Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17317024 | 0.80 | WNT3A (0.54) | WNT3APORCN | |
| SCHEMBL17675613 | 0.78 | WNT3A (0.61) | WNT3APORCN | |
| SCHEMBL16649515 | 0.78 | WNT3A (0.68) | WNT3APORCN | |
| SCHEMBL1723597 | 0.76 | WNT3A (1.00) | WNT3APORCN | |
| SCHEMBL12331945 | 0.76 | PORCN (0.73) | WNT3APORCN | |
| SCHEMBL17673081 | 0.76 | PORCN (0.60) | WNT3APORCN | |
| SCHEMBL1723533 | 0.75 | WNT3A (1.00) | WNT3APORCN | |
| SCHEMBL12303049 | 0.74 | WNT3A (0.84) | WNT3APORCN | |
| SCHEMBL12303069 | 0.74 | WNT3A (0.85) | WNT3APORCN | |
| SCHEMBL16649505 | 0.74 | PORCN (0.59) | WNT3APORCN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230201194-A1 | COMBINATION COMPOSITIONS FOR IMMUNOTHERAPY | CUREGENIX CORPORATION | 2023-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230201194-A1 | COMBINATION COMPOSITIONS FOR IMMUNOTHERAPY | WNT1, CTNNB1, WNT3 | WNT3A 4/4885PORCN 3182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.